CC
ROIV icon

Centiva Capital’s Roivant Sciences ROIV Stock Holding History

Centiva Capital’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-461,000
Closed -$10M – 1964
2025
Q4 		$10M Hold
461,000
– – 0.08% 162
2025
Q3 		$6.97M Buy
461,000
+81,100
+21% +$1M 0.07% 191
2025
Q2 		$4.28M Buy
+379,900
New +$4.12M 0.07% 162
2024
Q1 		– Sell
-200,000
Closed -$2.25M – 2173
2023
Q4 		$2.25M Buy
+200,000
New +$1.95M 0.05% 319

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Centiva Capital's ROIV Position: Q1 2026 in Review

Centiva Capital opened a new position in Roivant Sciences (ROIV) in Q1 2026: 7,596 shares worth $210K. The stake represents ﹤0.01% of the portfolio and ranks #1253 among its holdings. This is a return to the name: Centiva Capital previously reported a position in ROIV as recently as Q2 2024.

Centiva Capital first reported a position in ROIV in Q1 2022 and has held it in 8 quarters since. The position peaked at $2.06M in Q2 2022. 440 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Centiva Capital held 7,596 shares of Roivant Sciences worth $210K as of Q1 2026.
  • Roivant Sciences was a new Centiva Capital position in Q1 2026.
  • Roivant Sciences made up ﹤0.01% of Centiva Capital's portfolio in Q1 2026, its #1253 holding.
  • Centiva Capital first reported a position in Roivant Sciences in Q1 2022 and has held it in 8 quarters since.
  • Centiva Capital's Roivant Sciences position peaked at $2.06M in Q2 2022.
  • 440 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.